doi: 10.1155/2022/5632744 Summary Keywords anlotinib, malignant melanotic nerve sheath tumor, metastasis, radiotherapy, targeted therapy Citation Zhu H, Shen W, Yang H, Han X, Li W, Xie J, Tan Y, Lu P, Ji Y and Zhang Y (2026) Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor
PT-141 works by activating the melanocortin receptors in the brain, with a preference for the melanocortin-3 and melanocortin-4 receptors, which are known for their role in appetite, metabolism, and, most importantly, sexual function
What are the benefits of 5-Amino-1MQ dosage guide
Human Granuloma in Vitro Model, for TB Dormancy and Resuscitation